Novartis (Italy)
In research, Novartis (Italy) stands highest in Life Sciences (#2,599 of 14,347 worldwide), Medicine (#5,350 of 17,978 worldwide) and Health Sciences (#7,170 of 20,462 worldwide), over all time.
- World rank, all time
- #6,159 of 42,892
- Rank in Italy
- #199 of 969
- Research works
- 464 ▼ 64% vs 2013–17
- Citations
- 23k 49.2 per fractional work
- Top-10% rate
- 11.9% record average 16.5%
- Open access
- 51% world 28%
What is Novartis (Italy) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| Life SciencesDomain | #2,599 of 14,347 | 39.1% | 169 | |
| MedicineField | #5,350 of 17,978 | 33.6% | 243 | |
| Health SciencesDomain | #7,170 of 20,462 | 33.4% | 252 |
Each strip is that field’s whole ranked pool, with the notch where Novartis (Italy) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 5.5×. Every wedge is a field page.
- Immunology and Microbiology 5.5×
- Veterinary 5.5×
- Economics, Econometrics and Finance 4.8×
- Medicine 3.2×
- Pharmacology, Toxicology and Pharmaceutics 1.6×
- Biochemistry, Genetics and Molecular Biology 1.4×
- Chemistry 1.2×
- Health Professions 1.1×
- Dentistry 0.5×
- Psychology 0.4×
- Environmental Science 0.4×
- Neuroscience 0.2×
- Engineering 0.2×
- Physics and Astronomy 0.2×
- Mathematics 0.1×
- Social Sciences 0.1×
- Materials Science 0.1×
- Agricultural and Biological Sciences 0.0×
- Computer Science 0.0×
Who are the top researchers at Novartis (Italy)?
Ranked on the composite score, Rino Rappuoli lead among researchers whose main affiliation is Novartis (Italy).
- 1 Rino Rappuoli Italy · #24,390 worldwide 777 citations · 116 works
Which keywords describe research at Novartis (Italy)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Clinical Trials, Quality of Life, Genetic Variants, Cardiovascular Disease Prevention, Cholesterol-lowering, Statins, Cost-effectiveness Analysis and Health Utility Measures.
- Management
- Diagnosis
- Multiple Sclerosis
- Diagnostic Criteria
- Cost-effectiveness Analysis
- Cholesterol-lowering
- Genetic Variants
- Quality of Life
- Clinical Trials
- Epidemiology
- Cardiovascular Disease Prevention
- Statins
- Health Utility Measures
- Inflammation
- Neuromyelitis Optica
- Breast Cancer
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 16 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 16 words, with their numbers
- Clinical Trials3▲ 14×8 topics
- Quality of Life3▲ 6.2×8 topics
- Epidemiology2▲ 1.89×21 topics
- Genetic Variants2▲ 43×3 topics
- Cardiovascular Disease Prevention2▲ 82×2 topics
- Cholesterol-lowering2▲ 158×1 topic
- Statins2▲ 96×1 topic
- Cost-effectiveness Analysis2▲ 76×1 topic
- Health Utility Measures2▲ 76×1 topic
- Diagnostic Criteria2▲ 27×2 topics
- Inflammation2▲ 2.9×15 topics
- Multiple Sclerosis2▲ 152×1 topic
- Neuromyelitis Optica2▲ 152×1 topic
- Diagnosis2▲ 5.7×10 topics
- Breast Cancer1▲ 16×3 topics
- Management1▲ 5.0×5 topics
Which research topics does Novartis (Italy) publish most on?
By volume in 2022–2025: Lipoproteins and Cardiovascular Health, Health Systems, Economic Evaluations, Quality of Life, Multiple Sclerosis Research Studies and Advanced Breast Cancer Therapies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Lipoproteins and Cardiovascular Health Surgery 2 works
- 2 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 2 works
- 3 Multiple Sclerosis Research Studies Pathology and Forensic Medicine 2 works
- 4 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 1 works
- 5 Economic and Financial Impacts of Cancer Economics and Econometrics 1 works
- 6 Chronic Myeloid Leukemia Treatments Hematology 1 works
- 7 Breast Cancer Treatment Studies Cancer Research 0 works
- 8 Telemedicine and Telehealth Implementation Public Health, Environmental and Occupational Health 0 works
- 9 Complement system in diseases Immunology 0 works
- 10 Blood groups and transfusion Hematology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Novartis (Italy)'s research output changed?
Output in 2018–2022 was 64% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.